<SEC-DOCUMENT>0001140361-21-019538.txt : 20210602
<SEC-HEADER>0001140361-21-019538.hdr.sgml : 20210602
<ACCEPTANCE-DATETIME>20210602083125
ACCESSION NUMBER:		0001140361-21-019538
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20210602
FILED AS OF DATE:		20210602
DATE AS OF CHANGE:		20210602

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ICON PLC
		CENTRAL INDEX KEY:			0001060955
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
		IRS NUMBER:				981067160

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	333-08704
		FILM NUMBER:		21987759

	BUSINESS ADDRESS:	
		STREET 1:		SOUTH COUNTY BUSINESS PARK
		STREET 2:		LEOPARDSTOWN
		CITY:			DUBLIN 18
		STATE:			L2
		ZIP:			00000
		BUSINESS PHONE:		00 353 1 291 2000

	MAIL ADDRESS:	
		STREET 1:		SOUTH COUNTY BUSINESS PARK
		STREET 2:		LEOPARDSTOWN
		CITY:			DUBLIN 18
		STATE:			L2
		ZIP:			00000

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ICON PLC  /ADR/
		DATE OF NAME CHANGE:	20010213
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>nc10024440x9_6k.htm
<DESCRIPTION>6-K
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Finanicial Soultions, Inc.
         Document created using EDGARfilings PROfile 7.5.0.0
         Copyright 1995 - 2021 Broadridge -->
  </head>
<body style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;" bgcolor="#ffffff">
  <div>
    <div style="text-align: center; font-weight: bold;">
      <hr style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; margin-left: auto; margin-right: auto;" align="center"></div>
    <div style="text-align: center; font-weight: bold;"> <br>
    </div>
    <div style="text-align: center; font-weight: bold;">FORM 6-K</div>
    <div><br>
    </div>
    <div style="text-align: center; font-weight: bold;">SECURITIES AND EXCHANGE COMMISSION</div>
    <div><br>
    </div>
    <div style="text-align: center;">Washington, D.C. 20549</div>
    <div><br>
    </div>
    <div style="text-align: center; font-weight: bold;">Report of Foreign Private Issuer</div>
    <div style="text-align: center; font-weight: bold;">Pursuant to Rule 13a-16 under</div>
    <div style="text-align: center;">t<font style="font-weight: bold;">he Securities Exchange Act of 1934</font></div>
    <div><br>
    </div>
    <div style="text-align: center;">For the month ended June, 2021</div>
    <div><br>
    </div>
    <div style="text-align: center; font-weight: bold;">ICON plc</div>
    <div style="text-align: center;">(Registrant's name)</div>
    <div><br>
    </div>
    <div style="text-align: center; font-weight: bold;">333-08704</div>
    <div style="text-align: center;">&#160;(Commission file number)</div>
    <div><br>
    </div>
    <div style="text-align: center;">South County Business Park, Leopardstown, Dublin 18, Ireland</div>
    <div style="text-align: center;">(Address of principal executive offices)</div>
    <div><br>
    </div>
    <div style="text-align: center;">Brendan Brennan, CFO</div>
    <div style="text-align: center;">South County Business Park, Leopardstown, Dublin 18, Ireland.</div>
    <div style="text-align: center;">Brendan.Brennan@iconplc.com</div>
    <div style="text-align: center;">00-353-1-291-2000</div>
    <div style="text-align: center;">&#160;(Name, telephone number, email and/or facsimile number and address of Company contact person)</div>
    <div><br>
    </div>
    <div><br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="zc082d4832a7746f8afd029415d0f8ef2" cellpadding="0" cellspacing="0">

        <tr>
          <td colspan="3" style="width: 100%; vertical-align: top;">
            <div>Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 40%; vertical-align: top;">&#160;</td>
          <td style="width: 17%; vertical-align: top;">
            <div>Form 20-F __<font style="font-weight: bold;">X</font>___</div>
          </td>
          <td style="width: 43%; vertical-align: top;">
            <div>Form 40-F ______</div>
          </td>
        </tr>
        <tr>
          <td colspan="3" style="width: 100%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td colspan="3" style="width: 100%; vertical-align: top;">
            <div>Indicate by check mark whether the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):</div>
          </td>
        </tr>
        <tr>
          <td style="width: 40%; vertical-align: top;">&#160;</td>
          <td style="width: 17%; vertical-align: top;">
            <div>Yes______</div>
          </td>
          <td style="width: 43%; vertical-align: top;">
            <div>No___<font style="font-weight: bold;">X</font>___</div>
          </td>
        </tr>
        <tr>
          <td colspan="3" style="width: 100%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td colspan="3" style="width: 100%; vertical-align: top;">
            <div>Indicate by check mark whether the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):</div>
          </td>
        </tr>
        <tr>
          <td style="width: 40%; vertical-align: top;">&#160;</td>
          <td style="width: 17%; vertical-align: top;">
            <div>Yes______</div>
          </td>
          <td style="width: 43%; vertical-align: top;">
            <div>No___<font style="font-weight: bold;">X</font>___</div>
          </td>
        </tr>
        <tr>
          <td colspan="3" style="width: 100%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td colspan="3" style="width: 100%; vertical-align: top;">
            <div>Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the
              Commission pursuant to Rule12g3-2(b) under the Securities Exchange Act of 1934.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 40%; vertical-align: top;">&#160;</td>
          <td style="width: 17%; vertical-align: top;">
            <div>Yes______</div>
          </td>
          <td style="width: 43%; vertical-align: top;">
            <div>No___<font style="font-weight: bold;">X</font>___</div>
          </td>
        </tr>
        <tr>
          <td colspan="3" style="width: 100%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td colspan="3" style="width: 100%; vertical-align: top;">
            <div>If "Yes" is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b):82 <font style="font-weight: bold;">N/A</font></div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div>
      <hr style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;" align="center"></div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div>&#160;<font style="font-weight: bold;">ICON plc</font></div>
    <div><br>
    </div>
    <div>&#160;&#160;&#160;&#160;This report on Form 6-K is hereby incorporated by reference in the registration statement on Form F-3 (Registration No. 333-133371) of ICON plc and in the
      prospectus contained therein and in the registration statement on Form F-4 (Registration No. 333-254891) of ICON plc and in the prospectus contained therein, and this report on Form 6-K shall be deemed a part of each such registration statement from
      the date on which this report is filed, to the extent not superseded by documents or reports subsequently filed or furnished by ICON plc under the Securities Act of 1933 or the Securities Exchange Act of 1934.</div>
    <div><br>
    </div>
    <div style="text-indent: 36pt;">As previously disclosed, on February 24, 2021, ICON plc, a public limited company in Ireland (&#8220;ICON&#8221;), ICON US Holdings Inc., a Delaware
      corporation and subsidiary of ICON (&#8220;US HoldCo&#8221;), and Indigo Merger Sub, Inc., a Delaware corporation and subsidiary of ICON and US HoldCo (&#8220;Merger Subsidiary&#8221;) entered into an Agreement and Plan of Merger (the &#8220;Merger Agreement&#8221;) with PRA Health
      Sciences, Inc., a Delaware corporation (&#8220;PRA&#8221;). Upon the terms and subject to the conditions of the Merger Agreement, Merger Subsidiary will merge with and into PRA (the &#8220;Merger&#8221;), with PRA surviving as a subsidiary of ICON and US HoldCo.</div>
    <div><br>
    </div>
    <div style="text-indent: 36pt;">The completion of the Merger is conditioned upon, among other things, the approval of the Merger having been granted by the French Ministry
      of Economy and Finance and the Austrian Federal Ministry for Digital and Economic Affairs, in each case relating to the consummation of the Merger.&#160; These approvals have been obtained, and we have now obtained all regulatory approvals that are
      conditions to the closing of the Merger.</div>
    <div><br>
    </div>
    <div style="text-indent: 36pt;">The completion of the Merger remains subject to other customary closing conditions, including the adoption of the Merger Agreement by PRA&#8217;s
      stockholders and the approval by ICON&#8217;s shareholders of the issuance of ICON ordinary shares in the Merger. ICON expects the merger to close on July 1, 2021.</div>
    <div><br>
    </div>
    <div style="font-weight: bold;">Cautionary Note Regarding Forward-Looking Statements</div>
    <div><br>
    </div>
    <div style="text-indent: 36pt;">This communication contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section
      27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements generally include statements regarding the potential transaction between ICON and PRA, including any
      statements regarding the expected timetable for completing the potential transaction, the ability to complete the potential transaction, the expected benefits of the potential transaction (including anticipated synergies, projected financial
      information and future opportunities) and any other statements regarding ICON&#8217;s and PRA&#8217;s future expectations, beliefs, plans, objectives, results of operations, financial condition and cash flows, or future events or performance. These statements
      are often, but not always, made through the use of words or phrases such as &#8220;anticipate,&#8221; &#8220;intend,&#8221; &#8220;plan,&#8221; &#8220;believe,&#8221; &#8220;project,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;may,&#8221; &#8220;should,&#8221; &#8220;will&#8221; and similar expressions. All such forward-looking statements are based on
      current expectations of ICON&#8217;s and PRA&#8217;s management and therefore involve estimates and assumptions that are subject to risks, uncertainties and other factors that could cause actual results to differ materially from the results expressed in the
      statements. Key factors that could cause actual results to differ materially from those projected in the forward-looking statements include the ability to obtain the requisite ICON and PRA stockholder approvals; uncertainties as to the timing to
      consummate the potential transaction; the risk that a condition to closing the potential transaction may not be satisfied; the risk that regulatory approvals are not obtained or are obtained subject to conditions that are not anticipated by the
      parties; litigation relating to the potential transaction that has been or could be instituted against ICON, PRA or their respective directors; the effects of disruption to ICON&#8217;s or PRA&#8217;s respective businesses; restrictions during the pendency of
      the potential transaction that may impact ICON&#8217;s or PRA&#8217;s ability to pursue certain business opportunities or strategic transactions; the effect of this communication on ICON&#8217;s or PRA&#8217;s stock prices; transaction costs; ICON&#8217;s ability to achieve the
      benefits from the proposed transaction; ICON&#8217;s ability to effectively integrate acquired operations into its own operations; the ability of ICON or PRA to retain and hire key personnel; unknown liabilities; and the diversion of management time on
      transaction-related issues. Other important factors that could cause actual results to differ materially from those in the forward-looking statements include the effects of industry, market, economic, political or regulatory conditions outside of
      ICON&#8217;s or PRA&#8217;s control (including public health crises, such as pandemics and epidemics); risks regarding PRA&#8217;s ability to maintain large customer contracts or enter into new contracts; PRA&#8217;s ability to attract suitable investigators and patients
      for its clinical trials; PRA&#8217;s ability to keep pace with rapid technological change; PRA&#8217;s potential liability if a patient is harmed; and the factors set forth under the heading &#8220;Risk Factors&#8221; of ICON&#8217;s Annual Report on Form 20-F and PRA&#8217;s Annual
      Report on Form 10-K and most recent Quarterly Report on Form 10-Q, and in subsequent filings with the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;). These risks, as well as other risks associated with the potential transaction, are more fully
      discussed in the joint proxy statement/prospectus filed with the SEC in connection with the proposed transaction. Other unpredictable or unknown factors not discussed in this communication could also have material adverse effects on forward-looking
      statements. Neither ICON nor PRA assumes any obligation to update any forward-looking statements, except as required by law. Readers are cautioned not to place undue reliance on these forward-looking statements that speak only as of the date hereof.</div>
    <div><br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="font-weight: bold;">No Offer or Solicitation</div>
    <div><br>
    </div>
    <div style="text-indent: 36pt;">This communication does not constitute an offer to sell or the solicitation of an offer to buy any securities or a solicitation of any vote
      or approval, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offer of securities
      shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended.</div>
    <div><br>
    </div>
    <div style="font-weight: bold;">Important Information for Investors and Stockholders</div>
    <div><br>
    </div>
    <div style="text-indent: 36pt;">In connection with the potential transaction, ICON has filed a registration statement on Form F-4 (File No. 333-254891) with the SEC
      containing a prospectus of ICON that also constitutes a proxy statement of each of ICON and PRA. The registration statement, as amended, was declared effective, by the SEC on April 28, 2021.&#160; Each of ICON and PRA commenced mailing copies of the
      definitive joint proxy statement/prospectus to stockholders of ICON and PRA, respectively, on or about April 28, 2021.&#160; ICON and PRA may also file other documents with the SEC regarding the potential transaction. This communication is not a
      substitute for the joint proxy statement/prospectus or registration statement or for any other document that ICON or PRA have filed or may file with the SEC in connection with the potential transaction. INVESTORS AND SECURITY HOLDERS OF ICON AND PRA
      ARE URGED TO READ THE JOINT PROXY STATEMENT/PROSPECTUS AND OTHER DOCUMENTS THAT ARE FILED OR WILL BE FILED WITH THE SEC, AS WELL AS ANY AMENDMENTS OR SUPPLEMENTS TO THESE DOCUMENTS, CAREFULLY AND IN THEIR ENTIRETY BECAUSE THEY CONTAIN IMPORTANT
      INFORMATION. Investors and security holders are able to obtain free copies of the joint proxy statement/prospectus and other documents filed with the SEC by ICON or PRA through the website maintained by the SEC at http://www.sec.gov. Copies of the
      documents filed with the SEC by ICON are available free of charge on ICON&#8217;s website at https://www.iconplc.com and copies of the documents filed with the SEC by PRA are available free of charge on PRA&#8217;s website at https://www.prahs.com/.
      Additionally, copies may be obtained by contacting the investor relations departments of ICON or PRA.</div>
    <div><br>
    </div>
    <div>ICON and PRA and certain of their respective directors, certain of their respective executive officers and other members of management and employees may be
      considered participants in the solicitation of proxies with respect to the potential transaction under the rules of the SEC. Information about the directors and executive officers of ICON is set forth in its annual report on Form 20-F, which was
      filed with the SEC on February 24, 2021. Information about the directors and executive officers of PRA is set forth in its Amendment to Annual Report on Form 10-K/A for the fiscal year ended December 31, 2020, which was filed with the SEC on March
      30, 2021. These documents can be obtained free of charge from the sources indicated above. Additional information regarding the interests of such participants in the solicitation of proxies in respect of the potential transaction are included in the
      registration statement and joint proxy statement/prospectus and other relevant materials filed with the SEC.</div>
    <div><br>
    </div>
    <div>The term &#8220;ICON&#8221; and such terms as &#8220;the company,&#8221; &#8220;our,&#8221; &#8220;we,&#8221; &#8220;us&#8221; and &#8220;its&#8221; may refer to ICON public limited company, one or more of its consolidated
      subsidiaries, or to all of them taken as a whole. All of these terms are used for convenience only and are not intended as a precise description of any of the separate companies, each of which manages its own affairs.</div>
    <div><br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageBreak" style="page-break-after: always;">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" noshade="noshade"></div>
    </div>
    <div style="text-align: center; font-weight: bold;">SIGNATURES</div>
    <div><br>
    </div>
    <div>Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned
      thereunto duly authorized.</div>
    <div><br>
    </div>
    <div> <br>
    </div>
    <table style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="zb36fb1063b5e49b385c0647bc2fa99e5" cellpadding="0" cellspacing="0">

        <tr>
          <td style="width: 33.33%; vertical-align: middle;">&#160;</td>
          <td style="width: 33.33%; vertical-align: middle;">&#160;</td>
          <td style="width: 33.33%; vertical-align: middle;">
            <div style="font-weight: bold;">ICON plc</div>
          </td>
        </tr>
        <tr>
          <td style="width: 33.33%; vertical-align: middle;">&#160;</td>
          <td style="width: 33.33%; vertical-align: middle;">&#160;</td>
          <td style="width: 33.33%; vertical-align: middle;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 33.33%; vertical-align: middle;">&#160;</td>
          <td style="width: 33.33%; vertical-align: middle;">&#160;</td>
          <td style="width: 33.33%; vertical-align: middle;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 33.33%; vertical-align: middle;">&#160;</td>
          <td style="width: 33.33%; vertical-align: middle;">&#160;</td>
          <td style="width: 33.33%; vertical-align: middle;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 33.33%; vertical-align: middle;">&#160;</td>
          <td style="width: 33.33%; vertical-align: middle;">&#160;</td>
          <td style="width: 33.33%; vertical-align: middle; border-bottom: #000000 2px solid;">
            <div>/s/ Brendan Brennan</div>
          </td>
        </tr>
        <tr>
          <td style="width: 33.33%; vertical-align: top;">
            <div>Date: June 2, 2021</div>
          </td>
          <td style="width: 33.33%; vertical-align: middle;">&#160;</td>
          <td style="width: 33.33%; vertical-align: middle;">
            <div>Brendan Brennan</div>
            <div>Chief Financial Officer</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div><br>
    </div>
    <div>
      <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;" align="center" noshade="noshade"></div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
